Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond S M Wong

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Therapeutic Advances in Hematology|August 4, 2022
Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuriaRaymond S M Wong
Hematology/Oncology Clinics of North America|November 22, 2017
Unicentric Castleman DiseaseRaymond S M Wong
Emerging Infectious Diseases|March 20, 2004
Index patient and SARS outbreak in Hong KongRaymond S M Wong, David S Hui
Scandinavian Journal of Clinical and Laboratory Investigation|October 10, 2014
Thrombophilia in patients with chronic immune thrombocytopeniaRaymond S M Wong, Kalpana Bakshi, Andres Brainsky
Clinical and Experimental Pharmacology & Physiology|May 10, 2024
Erythropoietin hyporesponsiveness in non-alcoholic fatty liver diseaseHuixi Zou, Raymond S M Wong, Xiaoyu Yan
Biochemical Pharmacology|December 28, 2023
Thrombopoietin treats erythropoietin resistance by correcting EPO-induced progenitorcell depletionHuixi Zou, Raymond S M Wong, Xiaoyu Yan
British Journal of Pharmacology|April 23, 2024
Early erythroferrone levels can predict the long-term haemoglobin responses to erythropoiesis-stimulating agentsPeng Xu, Raymond S M Wong, Xiaoyu Yan
Journal of Pharmaceutical Sciences|November 1, 2023
The Influence of Precursor Depletion and dose Regimens on Resistance to Erythropoiesis-Stimulating Agents: Insights from Simulations with Instantaneous Dose-Adaptation AlgorithmPeng Xu, Raymond S M Wong, Xiaoyu Yan
Therapeutic Advances in Hematology|May 6, 2017
From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopagHarinder Gill, Raymond S M Wong, Yok-Lam Kwong
The Journal of Pharmacology and Experimental Therapeutics|April 30, 2022
Fate Determination Role of Erythropoietin and Romiplostim in the Lineage Commitment of Hematopoietic ProgenitorsXiaoqing Fan, Wojciech Krzyzanski, Raymond S M Wong, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Therapeutic Advances in Hematology|August 4, 2022
Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuriaRaymond S M Wong
Hematology/Oncology Clinics of North America|November 22, 2017
Unicentric Castleman DiseaseRaymond S M Wong
Emerging Infectious Diseases|March 20, 2004
Index patient and SARS outbreak in Hong KongRaymond S M Wong, David S Hui
Scandinavian Journal of Clinical and Laboratory Investigation|October 10, 2014
Thrombophilia in patients with chronic immune thrombocytopeniaRaymond S M Wong, Kalpana Bakshi, Andres Brainsky
Clinical and Experimental Pharmacology & Physiology|May 10, 2024
Erythropoietin hyporesponsiveness in non-alcoholic fatty liver diseaseHuixi Zou, Raymond S M Wong, Xiaoyu Yan
Biochemical Pharmacology|December 28, 2023
Thrombopoietin treats erythropoietin resistance by correcting EPO-induced progenitorcell depletionHuixi Zou, Raymond S M Wong, Xiaoyu Yan
British Journal of Pharmacology|April 23, 2024
Early erythroferrone levels can predict the long-term haemoglobin responses to erythropoiesis-stimulating agentsPeng Xu, Raymond S M Wong, Xiaoyu Yan
Journal of Pharmaceutical Sciences|November 1, 2023
The Influence of Precursor Depletion and dose Regimens on Resistance to Erythropoiesis-Stimulating Agents: Insights from Simulations with Instantaneous Dose-Adaptation AlgorithmPeng Xu, Raymond S M Wong, Xiaoyu Yan
Therapeutic Advances in Hematology|May 6, 2017
From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopagHarinder Gill, Raymond S M Wong, Yok-Lam Kwong
The Journal of Pharmacology and Experimental Therapeutics|April 30, 2022
Fate Determination Role of Erythropoietin and Romiplostim in the Lineage Commitment of Hematopoietic ProgenitorsXiaoqing Fan, Wojciech Krzyzanski, Raymond S M Wong, et al.
Pageof 7